You are here: Industry Insights > Bharat Biotech

News List

Ocugen to seek full approval for Bharat Biotech’s Covaxin in the US pharmaceutical-technology
June 15, 2021
Ocugen has plans to seek full approval for Bharat Biotech’s Covid-19 vaccine candidate, Covaxin, in the US, after the Food and Drug Administration (FDA) declined to grant an Emergency Use Authorization (EUA).
Bharat Biotech shares full research data of COVAXIN expresspharma
June 15, 2021
Bharat Biotech has shared full data of all research studies of COVAXIN, its COVID-19 vaccine.
Ocugen, Bharat Biotech sign agreement for commercialisation rights to COVAXIN in Canada expresspharma
June 04, 2021
Similar to the US profit share arrangement, Ocugen will retain 45 per cent of the profits from sales of COVAXIN in Canada.
Bharat Biotech and Gujarat Covid Vaccine Consortium sign MoU for drug substance of COVAXIN expresspharma
May 31, 2021
An MOU has been signed between Bharat Biotech International and Gujarat Covid Vaccine Consortium (GCVC) towards contract manufacturing for the Drug Substance for COVAXIN.
120 days to make, test and release each Covaxin batch: Bharat Biotech expresspharma
May 31, 2021
Production scale-up of vaccines is a step-by-step process, involving several regulatory SOPs of GMP. There is a four-month lag time for Covaxin to translate into actual vaccination, a statement by the company said.
Uzbekistan invites Indian companies to explore JVs in seven pharmacological free zones expresspharma
May 26, 2021
This opens space for Serum Institute, Bharat Biotech and other Indian vaccine makers to explore joint manufacturing and development of new vaccines with their peers in Uzbekistan.
Bharat Biotech may begin paediatric trials of COVAXIN in June expresspharma
May 26, 2021
Bharath Biotech has received permission to carry out paediatric trials of the vaccine and it may commence trials from June 1.
Paediatric trials of Covaxin are likely to start from June 1: Dr Raches Ella expresspharma
May 24, 2021
Bharat Biotech is ramping up its manufacturing capacity to 700 million doses which are likely to be achieved by the end of this year, said Dr Raches Ella.
Bharat Biotech ramps up COVAXIN production volumes by additional 200 million expresspharma
May 21, 2021
Bharat Biotech announced the ramp-up of additional manufacturing capacities for COVAXIN at Chiron Behring Vaccines, Ankleshwar Gujarat, a wholly-owned subsidiary of Bharat Biotech.
Bharat Biotech’s Karnataka facility will be able to make 4-5 cr Covaxin doses a month by Aug end: Minister expresspharma
May 19, 2021
He also said that Bharat Biotech's facility in Hyderabad can produce one crore doses of COVID vaccine a month.

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page